-

$undefined

N/A

(N/A)

Journey Medical Corporation NASDAQ:DERM Journey is focused on identifying, acquiring and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model. The Journey team is comprised of industry experts with extensive experience commercializing some of the most successful prescription dermatology brands. Journey was formed in 2014 and is a subsidiary of Fortress Biotech, Inc. Journey’s core purpose is to positively impact people’s lives and well-being by providing effective solutions for treating skin conditions, healing wounds and supporting healthy skin.

Location: | Website: journeymedicalcorp.com | Industry: Medicinal and Botanical Manufacturing | Sector: Manufacturing

Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

171.5M

Cash

20.31M

Avg Qtr Burn

-2.282M

Short % of Float

1.05%

Insider Ownership

26.12%

Institutional Own.

22.18%

Qtr Updated

12/31/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Emrosi™ (Formerly DFD-29) Details Papulopustular rosacea	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.